InvestorsHub Logo
Followers 7
Posts 789
Boards Moderated 0
Alias Born 11/20/2003

Re: ronpopeil post# 11701

Tuesday, 03/14/2017 10:53:26 AM

Tuesday, March 14, 2017 10:53:26 AM

Post# of 12450
While the CEO who is a scientist like the mad professor has been running this company for years and was only able to get for Tivoli off the ground yielding 6times ROI that has kept this company going. While rival port that they licensed to Redhill if it would have been approved on time would have produced revenues.The problem with the mfg API ingredients and the
non FDA approval of the mfg plant screwed the pooch for this drug while competitors kept moving forward.

They now realized that they had to control their own destiny by having their own mfg plant in which they got low interest funding.

Their old Indian president was ineffective who was fired. The new people on the team have been inking deals.

They still have their PARRA-NEW drugs that yet to bear fruit and don't know the timetable for launch and hence,sales

They were able to sell their royalty stream for $6M Canadian to keep the lights on till revenues come in from sales next year

There is still litigation to be settled on their Suboxone drug.

I think maybe people are tired of waiting since the biotechnology sector that did not do well last year is moving along briskly.

I think they only have one choice to get the stock PPS up that is they have to bring revenues in as I do not think they will want to dilute the PPS at these prices
or go out of business or be sold at a cheap price. I don't think that Horst will do that as this is his baby and after all these years wants to be recognized and have his day in the sun
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IGXT News